PATH | VRL
Menu

Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-Effectiveness Analyses

This supplement to Vaccine contains 38 articles featuring country-led research to support real-time policymaking, including cost-effectiveness, program costing, and analyses of financial flows for vaccine introduction. It highlights work undertaken in collaboration with the Pan American Health Organization’s ProVac Initiative, which promotes the development and use of evidence as the basis for decision-making regarding new vaccine introduction. The supplement includes articles related to the costs and financing of routine immunization broadly, as well as articles focused on the introduction costs of specific vaccines. ABSTRACTS ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Andrus JK, Walker DG, eds.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Andrus JK, Walker DG, eds. Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-Effectiveness Analyses. Vaccine. 2015;33(Suppl 1):A1-A254.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV), Meningococcus, Pneumococcus, Rotavirus

Topics: Introduction and service delivery, Immunization financing, Disease/vaccine specific information

Regions: Global